Background: Cysteine-rich secretory protein 2 (CRISP2) is an important sperm protein and plays roles in spermatogenesis, modulation of flagellar motility, acrosome reaction, and gamete fusion. Clinical evidence shows a reduced CRISP2 expression in spermatozoa from asthenozoospermic patients, but the molecular mechanism underlying its reduction remains unknown. Herein, we carried out a study focusing on the CRISP2 reduction and its roles in asthenozoospermia Methods: Spermatozoa were isolated from 90 study subjects' ejaculated semen samples. DNA methylation was evaluated using bisulfite-sequencing PCR and methylationspecific PCR. The CRISP2 mRNA and protein expression levels were examined in the ejaculated spermatozoa by qRT-PCR and Western blot respectively. miRNA expression was detected by qRT-PCR. The direct regulatory effect of miR27b on CRISP2 was predicted computationally and validated via luciferase reporter assay and in vitro experiments in which miR-27b mimic or inhibitor was transfected into 293T cells. Respective correlations of miR-27b and CRISP2 protein expression with clinical features were analyzed using Spearman's correlation coefficient. Results: Initially, low expression of CRISP2 protein rather than its mRNA was observed in the ejaculated spermatozoa from asthenozoospermic patients relative to normozoospermic males. Meanwhile, methylation was not found in CRISP2 promoter. These data suggest a possible post-transcriptional regulation of CRISP2 in asthenozoospermia. Subsequently, bioinformatics prediction, luciferase reporter assay and miR-27b transfection experiments revealed that miR-27b could specifically target CRISP2 by binding its 3'-UTR, suppressing CRISP2 expression post-transcriptionally. Further evidence was provided by the clinical observation of a high miR-27b expression in the ejaculated spermatozoa from asthenozoospermic patients and a negative correlation between miR-27b and CRISP2 protein expression. Finally, a retrospective follow-up study supported that both high miR-27b expression and low CRISP2 protein expression were associated with low sperm progressive motility, abnormal morphology and infertility. Conclusions: This study provides the first preliminary insight into the mechanism leading to the reduced CRISP2 expression in asthenozoospermia, offering a potential therapeutic target for treating male infertility or for male contraception.
AB036. Effects and its potential mechanisms of Cox-2 inhibitors on ejaculation latency of rat with experimental autoimmune prostatitis
Background: To investigate the effects and its potential mechanisms of Cox-2 inhibitors on ejaculation latency of rat with experimental autoimmune prostatitis (EAP). Methods: Thirty six male Wistar rats with normal sexual function were screened by using the copulatory test, and were randomly divided into 3 groups: the model group (n=16), the normal control group (n=10) and the celecoxib treatment group (n=10). EAP rat model was established in the model group and the celecoxib treatment group by subcutaneous multiple point's injection of male prostate gland extract emulsified in an equal volume of Freund's adjuvant at the 0 and 21th day. Control animals received equal volume of saline. From the 0th day, the celecoxib treatment group was given a gavage of celecoxib (18 mg·kg ). Eight weeks later, the sexual behavior was investigated by the copulatory test, the morphological change of prostatic tissue was observed by light microscopy after HE staining, cytokines (TNF-α, IL-1β) in serum were detected by ELISA, the levels of 5-HT, 5-HT1A receptor, 5-HT2C receptor and SERT in T13-L2 and L5-S2 spinal cord tissue were detected by immunohistochemical staining and Western Blot. Results: In model group, prostatic inflammation was found in 12 rats, and not in another 4 rats. The 4 rats were not included in the statistical analysis. In normal control group, prostatic inflammation was not found. In the celecoxib treatment group, there was a small amount of interstitial infiltration of inflammatory cells in rat's prostate. In the copulatory test, compared with normal control group, mount latency (ML) and intromission latency (IL) in the model group were significantly prolonged (P<0.05); ejaculation latency (EL) in the model group was significantly shortened (P<0.05). There was no significant difference in these sexual behavior parameters between the normal control group and the celecoxib treatment group (P>0.05). Serum IL-1β and TNF-α levels in the model group were significantly higher than that in the control group (P<0.01). There was no significant difference in the levels of IL-1β and TNF-α between the normal control group and the celecoxib treatment group (P>0.05). In T13-L2 spinal cord tissue, compared with normal control group, 5-HT levels in the model group were significantly lower (P<0.05), 5-HT1A receptor levels in the model group were significantly increased (P<0.05), while the 5-HT2C receptor and SERT levels in the model group did not change significantly (P>0.05). In L5-S2 spinal cord tissues, compared with normal control group, 5-HT levels in the model group were significantly lower (P<0.05), while the 5-HT1A, 5-HT2C and SERT levels in the model group increased slightly, but the differences in 5-HT1A, 5-HT2C and SERT levels between the model group and the normal control group were statistically significant (P<0.05). There were not significant differences in 5-HT, 5-HT1A, 5-HT2C and SERT levels between the normal control group and the celecoxib treatment group (P>0.05). Conclusions: EAP shorten rat's EL by changing the levels of 5-HT and its receptors, SERT in spinal cord. Cox-2 inhibitors can prolong EL of EAP rat, the mechanisms might be that it can relieve inflammation of the prostate, reverse the effect of EAP on spinal cord 5-HT transmitter system. Cox-2 inhibitors can be used in the treatment of premature ejaculation caused by prostatitis. Background: To investigate the changes of miR-155/ endothelial nitric oxide synthase (eNOS) signal pathway under the stimulation of age-BSA and glucose with or without icariside II (ICAII) intervention inhuman cavernous endothelial cells (HCECs). Methods: Purified HCECs were first divided into three groups randomly: normal group + BSA (NC group), age-BSA + glucose group (DM group), ICAII treatment group (DM + ICAII group with different concentrations at 0.1, 1, 10 μM). Western Blot to detect the protein expression of eNOS and RAGE; real time PCR to detect the expression of miR-155 and eNOS; DAF-FM DA fluorescent probes assay and NaNO 3 /NaNO 2 assay to detect the NO concentration. Lentivirus mediated miR-155 overexpression was constructed to observe the changes of eNOS and NO. Results: The eNOS and RAGE expression in DM group is significantly reduced and increased respectively compared with that of NC group (P<0.05), while ICAII intervention could reverse this change effectively. The
